FDA Approves New Cystic Fibrosis Drug
FDA Approves New Cystic Fibrosis Drug
The treatment, Trikafta, increases lung function in most patients with the disease—but comes with a hefty price tag.
FDA Approves New Cystic Fibrosis Drug
FDA Approves New Cystic Fibrosis Drug

The treatment, Trikafta, increases lung function in most patients with the disease—but comes with a hefty price tag.

The treatment, Trikafta, increases lung function in most patients with the disease—but comes with a hefty price tag.

food and drug administration
Antidepressant Approvals Could Herald New Era in Psychiatric Drugs
Antidepressant Approvals Could Herald New Era in Psychiatric Drugs
Bianca Nogrady | Oct 1, 2019
The FDA has given the green light to the first major new classes of antidepressant therapies in decades, opening up new avenues for therapeutic development.
First New Tuberculosis Drug Approved in 50 Years
First New Tuberculosis Drug Approved in 50 Years
Jef Akst | Aug 15, 2019
The US Food and Drug Administration green lights a therapy for an extreme form of multidrug resistant TB.
Survey of Stem Cell Clinics Reveals Cause for Concern
Survey of Stem Cell Clinics Reveals Cause for Concern
Jef Akst | Aug 1, 2019
Two coauthors of a new study discuss their findings about nearly 170 facilities in the southwestern US selling unproven therapies—and what should be done about them.
Sunscreen Ingredients Absorbed into Blood: Study
Sunscreen Ingredients Absorbed into Blood: Study
Catherine Offord | May 7, 2019
FDA researchers report that multiple active ingredients wind up in users’ bloodstream and recommend toxicology testing to investigate the clinical significance of the findings.
FDA Lifts Import Restrictions on Genetically Engineered Salmon
FDA Lifts Import Restrictions on Genetically Engineered Salmon
Catherine Offord | Mar 11, 2019
The fast-growing fish can now be raised and sold in the US, although it’s likely to be some time before the product hits the market.
A Landmark Study On BPA Leaves Scientists at Odds
A Landmark Study On BPA Leaves Scientists at Odds
Shawna Williams | Oct 26, 2018
Conceived as a way to resolve differences between government regulators and academics over the chemical’s effects, the CLARITY-BPA collaboration instead highlights divisions.
Two CAR T-Cell Therapies Greenlighted in Europe
Two CAR T-Cell Therapies Greenlighted in Europe
Jef Akst | Aug 28, 2018
Cancer treatments from Novartis and Gilead earn approval from EU regulators, but a first pass by the UK’s state-funded health service finds CAR T is too expensive. 
Questions Raised About “Breakthrough” Therapies’ Clinical Support
Questions Raised About “Breakthrough” Therapies’ Clinical Support
Catherine Offord | Jul 17, 2018
Compared to other drugs, therapeutics given breakthrough status receive FDA approval on the basis of weaker trial evidence, a study finds.
Supreme Court Nominee Draws Concern from Environmentalists
Supreme Court Nominee Draws Concern from Environmentalists
Catherine Offord | Jul 10, 2018
President Trump’s pick, Judge Brett Kavanaugh, has often opposed court involvement in environmental and health regulations.